Overseas news | Weixinkang wonderful appearance CPHI Worldwide 2023
From October 24 to 26, CPHI Worldwide 2023 was grandly launched in Barcelona Convention and Exhibition Center, Spain. Weixinkang brought many core products in the field of apis and preparations to the CPHI exhibition. Keep up with industry trends and continue to expand international cooperation
Tibet Weixinkang Pharmaceutical Co., Ltd. at CPHI China 2023 to join hands with global partners for a win-win situation
The 21st CPHI China 2023, organized by Informa Markets and China Chamber of Commerce for Import and Export of Pharmaceuticals and Healthcare Products and co-organized by Shanghai UBM Sinoexpo, was held at Shanghai Pudong New International Expo Centre from 19 to 21 June. Weixin Kang Pharmaceuticals made a splendid appearance at this year's CPHI, showcasing its core products in the field of APIs and formulations, and discussing cooperation and development with customers from all over the world.
-
Weixin Kang's Amino Acid Injection (20AA) is approved for marketing!
Recently, Inner Mongolia Baiyi Pharmaceutical Co., Ltd. , a wholly-owned subsidiary of Weixin Kang, received the "Certificate of Drug Registration" (Drug Approval No.: GYZZ H20223734) for Compound Amino Acid Injection (20AA), which was approved and issued by the State Drug Administration. The company has already started the pre-production preparation work and the launch of this product will bring new treatment options for patients.
Read more 2022/11/15 -
Integrated layout accelerated Two subsidiaries of Weixin Kang obtain B certificate for drug production
August 18, 2021, Beijing Jingweixinkang Pharmaceutical Technology Development Co.,Ltd.
Read more 2021/12/15 -
2019 China Pharmaceutical Newcomer Award" - Wei You Jia and Wei Jin Chang
On December 3, 2019, the "10th Pharmaceutical Observer Emerging Forum" was held in Chongqing City, with nearly 1,000 participants including pharmaceutical-related government officials, pharmaceutical experts and scholars, entrepreneurs and pharmaceutical elites at large.
Read more 2020/03/25